Chronic stress promoted the growth of ovarian carcinoma via: Increasing serum levels of norepinephrine and interleukin-10 and altering nm23 and NDRG1 expression in tumor tissues in nude mice

BioScience Trends

Volumn 7, Issue 1, 2013, Pages 56-63

  Gao, Guolan ^a   Sun, Jianling ^a   Gao, Jun ^a   Xiong, Lijuan ^a   Yu, Liqun ^a   Gao, Yulian ^a  

^a Aviation General Hospital   (China)

Author keywords

Chronic stress; Interleukin 10; NDRG1; nm23; Norepinephrine; Ovarian carcinoma

Indexed keywords

CELL CYCLE PROTEIN; INTERLEUKIN 10; N MYC DOWNSTREAM REGULATED GENE 1 PROTEIN; N-MYC DOWNSTREAM-REGULATED GENE 1 PROTEIN; NORADRENALIN; NUCLEOSIDE DIPHOSPHATE KINASE NM23; SIGNAL PEPTIDE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; CARCINOMA; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOTIVATION; MOUSE; NUDE MOUSE; OVARY TUMOR; PATHOLOGY; PHYSIOLOGICAL STRESS; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CARCINOMA; CELL CYCLE PROTEINS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HANDLING (PSYCHOLOGY); HUMANS; INTERLEUKIN-10; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; NOREPINEPHRINE; OVARIAN NEOPLASMS; STRESS, PHYSIOLOGICAL; TRANSPLANTATION, HETEROLOGOUS;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 84875940863     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: 10.5582/bst.2013.v7.1.56     Document Type: Article

References (40)

1. GLOBOCAN 2008. World Health Organization. http://globocan.iarc.fr/ (accessed December 21, 2012).
2. Mandic A, Tesic M, Vujkov T, Novta N, Rajovic J. Ovarian cancer stage III/IV: Poor prognostic factors. Arch of Oncol. 2001; 9:13-16.
3. Li Z, Zhao X, Yang J, Wei Y. Proteomics profile changes in cisplatin-treated human ovarian cancer cell strain. Sci China C Life Sci. 2005; 48:648-657.
4. De Marco C, Rinaldo N, Bruni P, Malzoni C, Zullo F, Fabiani F, Losito S, Scrima M, Marino FZ, Franco R, Quintiero A, Agosti V, Viglietto G. Multiple genetic alterations within the PI3K pathway are responsible for AKT activation in patients with ovarian carcinoma. PLoS One. 2013; 8:e55362.
5. Garssen B. Psychological factors and cancer development: evidence after 30 years of research. Clin Psychol Rev. 2004; 24:315-338.
6. Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol. 2008; 5:466-475.
7. Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH, Li Y, Gershenson DM, Lutgendorf S, Cole SW. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res. 2006; 12:369-375.
8. Yuan A, Wang S, Li Z, Huang C. Psychological aspect of cancer: From stressor to cancer progression. Exp Ther Med. 2010; 1:13-18.
9. Thaker PH, Han LY, Kamat AA, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006; 12:939-944.
10. Alfonso J, Frick LR, Silberman DM, Palumbo ML, Genaro AM, Frasch AC. Regulation of hippocampal gene expression is conserved in two species subjected to different stressors and antidepressant treatments. Biol Psychiatry. 2006; 59:244-251.
11. Sheridan JF, Dobbs C, Jung J, Chu X, Konstantinos A, Padgett D, Glaser R. Stress-induced neuroendocrine modulation of viral pathogenesis and immunity. Ann N Y Acad Sci. 1998; 840:803-808.
12. Shi W, Siemann DW. Inhibition of renal cell carcinoma angiogenesis and growth by antisense oligonucleotides targeting vascular endothelial growth factor. Br J Cancer. 2002; 87:119-126.
13. Winter D, Kugelstadt D, Seidler J, Kappes B, Lehmann WD. Protein phosphorylation influences proteolytic cleavage and kinase substrate properties exemplified by analysis of in vitro phosphorylated Plasmodium falciparum glideosome-associated protein 45 by nanoultra performance liquid chromatography-tandem mass spectrometry. Anal Biochem. 2009; 393:41-47.
14. Kandala PK, Srivastava SK. Regulation of Janusactivated kinase-2 (JAK2) by diindolylmethane in ovarian cancer in vitro and in vivo. Drug Discov Ther. 2012; 6:94-101.
15. Bao GY, Wang HZ, Shang YJ, Fan HJ, Gu ML, Xia R, Qin Q, Deng AM. Quantitative proteomic study identified cathepsin B associated with doxorubicininduced damage in H9c2 cardiomyocytes. Biosci Trends. 2012; 6:283-287.
16. An YT, Zhao Z, Sheng YC, Min Y, Xia YY. Therapeutic time window of YGY-E neuroprotection of cerebral ischemic injury in rats. Drug Discov Ther. 2011; 5:76-83.
17. Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: Implications for health. Nat Rev Immunol. 2005; 5:243-251.
18. Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004; 5:617-625.
19. Padgett DA, Glaser R. How stress influences the immune response. Trends Immunol. 2003; 24:444-448.
20. Segerstrom SC, Miller GE. Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psychol Bull. 2004; 130:601-630.
21. Sato T, Terai M, Tamura Y, Alexeev V, Mastrangelo MJ, Selvan SR. Interleukin 10 in the tumor microenvironment: A target for anticancer immunotherapy. Immunol Res. 2011; 51:170-182.
22. Antoni MH, Lutgendorf SK, Cole SW, Dhabhar FS, Sephton SE, McDonald PG, Stefanek M, Sood AK. The influence of bio-behavioural factors on tumour biology: Pathways and mechanisms. Nat Rev Cancer. 2006; 6:240-248.
23. Lutgendorf SK, Cole S, Costanzo E, Bradley S, Coffin J, Jabbari S, Rainwater K, Ritchie JM, Yang M, Sood AK. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res. 2003; 9:4514-4521.
24. Hall RA. Beta-adrenergic receptors and their interacting proteins. Semin Cell Dev Biol. 2004; 15:281-288.
25. Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nat Rev Cancer. 2007; 7:79-94.
26. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, Sobel ME. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst. 1988; 80:200-204.
27. Florenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, Fodstad O. Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res. 1992; 52:6088-6091.
28. Nakayama T, Ohtsuru A, Nakao K, Shima M, Nakata K, Watanabe K, Ishii N, Kimura N, Nagataki S. Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product. J Natl Cancer Inst. 1992; 84:1349-1354.
29. Ozeki Y, Takishima K, Mamiya G. Immunohistochemical analysis of nm23/NDP kinase expression in human lung adenocarcinoma: association with tumor progression in Clara cell type. Jpn J Cancer Res. 1994; 85:840-846.
30. Hailat N, Keim DR, Melhem RF, Zhu XX, Eckerskorn C, Brodeur GM, Reynolds CP, Seeger RC, Lottspeich F, Strahler JR, et al. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest. 1991; 88:341-345.
31. Leone A, Flatow U, VanHoutte K, Steeg PS. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: Effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene. 1993; 8:2325-2333.
32. Royds JA, Cross SS, Silcocks PB, Scholefield JH, Rees RC, Stephenson TJ. Nm23 'anti-metastatic' gene product expression in colorectal carcinoma. J Pathol. 1994; 172:261-266.
33. Youn BS, Kim DS, Kim JW, Kim YT, Kang S, Cho NH. NM23 as a prognostic biomarker in ovarian serous carcinoma. Mod Pathol. 2008; 21:885-892.
34. Schneider J, Pollan M, Jimenez E, Marenbach K, Martinez N, Volm M, Marx D, Meden H. nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinoma. Br J Cancer. 2000; 82:1662-1670.
35. Okuda T, Kokame K, Miyata T. Functional analyses of NDRG1, a stress-responsive gene. Seikagaku. 2005; 77:630-634.
36. Melotte V, Qu X, Ongenaert M, van Criekinge W, de Bruine AP, Baldwin HS, van Engeland M. The N-myc downstream regulated gene (NDRG) family: Diverse functions, multiple applications. FASEB J. 2010; 24:4153-4166.
37. Zhao G, Chen J, Deng Y, Gao F, Zhu J, Feng Z, Lv X, Zhao Z. Identification of NDRG1-regulated genes associated with invasive potential in cervical and ovarian cancer cells. Biochem Biophys Res Commun. 2011; 408:154-159.
38. Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM, Pardee AB. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res. 2000; 60:749-755.
39. Bandyopadhyay S, Pai SK, Gross SC, Hirota S, Hosobe S, Miura K, Saito K, Commes T, Hayashi S, Watabe M, Watabe K. The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res. 2003; 63:1731-1736.
40. Ellen TP, Ke Q, Zhang P, Costa M. NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis. 2008; 29:2-8.